Geller Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.32M Sell
2,527
-1
-0% -$521 0.09% 55
2024
Q3
$1.24M Sell
2,528
-1,046
-29% -$487K 0.09% 62
2024
Q2
$1.59M Buy
3,574
+28
+0.8% +$11.2K 0.12% 48
2024
Q1
$1.42M Buy
3,546
+65
+2% +$24.6K 0.11% 48
2023
Q4
$1.17M Sell
3,481
-7
-0.2% -$2.09K 0.11% 55
2023
Q3
$1.02M Sell
3,488
-116
-3% -$36.2K 0.12% 54
2023
Q2
$1.23M Buy
3,604
+2,349
+187% +$711K 0.15% 40
2023
Q1
$321K Buy
1,255
+125
+11% +$30.8K 0.05% 114
2022
Q4
$300K Buy
1,130
+13
+1% +$3.17K 0.05% 95
2022
Q3
$209K Buy
+1,117
New +$240K 0.05% 122
2022
Q2
Sell
-972
Closed -$293K 155
2022
Q1
$293K Sell
972
-40
-4% -$11.7K 0.05% 111
2021
Q4
$364K Buy
1,012
+1
+0.1% +$344 0.07% 95
2021
Q3
$335K Sell
1,011
-54
-5% -$18.1K 0.07% 92
2021
Q2
$326K Buy
1,065
+18
+2% +$5.05K 0.07% 84
2021
Q1
$258K Buy
1,047
+246
+31% +$61.9K 0.06% 94
2020
Q4
$258K Buy
+801
New +$199K 0.06% 87

Other funds holding ISRG

Geller Advisors's ISRG Position: Q4 2024 in Review

Geller Advisors reduced its Intuitive Surgical (ISRG) stake by 0.04% in Q4 2024, selling an estimated $521 and leaving 2,527 shares worth $1.32M. The position accounts for 0.09% of the portfolio, ranked #55.

Geller Advisors first reported a position in ISRG in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.59M in Q2 2024. 2,129 funds tracked by Wall St. Rank hold ISRG as of Q4 2024.

  • Geller Advisors held 2,527 shares of Intuitive Surgical worth $1.32M as of Q4 2024.
  • Geller Advisors sold 1 Intuitive Surgical share in Q4 2024, an estimated $521.
  • Intuitive Surgical made up 0.09% of Geller Advisors's portfolio in Q4 2024, its #55 holding.
  • Geller Advisors first reported a position in Intuitive Surgical in Q4 2020 and has held it in 16 quarters since.
  • Geller Advisors's Intuitive Surgical position peaked at $1.59M in Q2 2024.
  • 2,129 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.